Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kafra-MS Oral Suspension

Prescription Icon
Prescription Required

Marketer

Biotric Healthcare Pvt Ltd

Salt Composition

Ofloxacin (50mg/5ml) + Metronidazole (120mg/5ml) + Simethicone (10mg/5ml)

Overview Kafra-MS Oral Suspension

Pediatric patients receive Kafra-MS Oral Suspension to combat bacterial infections affecting the teeth, respiratory system, digestive system, urinary tract, and reproductive organs. This antibiotic is also used empirically to treat bloody diarrhea and severe infections such as peritonitis. Administer Kafra-MS Oral Suspension orally to your child, ideally at a consistent time, either before or after meals; if stomach upset occurs, administer with food. The usual dosage is twice daily, morning and evening. If vomiting happens within 30 minutes, repeat the dose; however, avoid doubling the dose if it's nearly time for the next scheduled administration. Never adjust the prescribed dosage, timing, or method, as these factors are tailored to the infection's type and severity, your child's age, and weight. Minor, transient side effects, such as nausea, vomiting, weight loss, a metallic taste, headache, decreased appetite, abdominal pain, and mild rash, may occur. These typically subside with continued use. If side effects persist or worsen, promptly consult your child's physician. Always provide your child's full medical history to their doctor, including any prior allergic reactions, cardiac issues, liver problems, or kidney dysfunction. This comprehensive information is crucial for precise dosage and effective treatment planning.

Uses of Kafra-MS Oral Suspension

Managing Bacterial Infections

Major Benefits of Kafra-MS Oral Suspension:

Administer this medication according to your physician's prescribed dosage and schedule. Consult the product label for complete instructions prior to ingestion. Use a measuring device for accurate dispensing and oral consumption. Ensure thorough shaking before each use. Kafra-MS Oral Suspension can be ingested with or without food; however, consistent timing is recommended.

Common Side effects of Kafra-MS Oral Suspension:

  • Vomiting
  • Nausea
  • Weight loss
  • Abdominal pain
  • Headache
  • Diarrhea
  • Loss of appetite
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Metallic taste
  • Urine discoloration

How to use Kafra-MS Oral Suspension:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Always consult the product label for detailed instructions prior to consumption. Use a measuring cup for accurate dosing and ingest orally. Ensure thorough shaking before each use. Kafra-MS Oral Suspension can be ingested with or without food; however, consistent timing is recommended for optimal results.

How Kafra-MS Oral Suspension works:

Kafra-MS Oral Suspension unites three active components to combat infection and alleviate related digestive discomfort. Ofloxacin and metronidazole, both antibiotics, target bacterial DNA, hindering its function and thus eliminating infection. Simethicone, a distinct gas-reducing agent, enhances the formulation's digestibility. It achieves this by binding to gas pockets, whether produced by the antibiotics or other sources, promoting their expulsion and relieving associated abdominal pain and distension.

SAFETY ADVICE

KidneyKidneyCAUTION

Patients with impaired kidney function should use Kafra-MS Oral Suspension judiciously. Dosage modification of Kafra-MS Oral Suspension might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should exercise caution when using Kafra-MS Oral Suspension. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Kafra-MS Oral Suspension :

Remain calm. Administer the medication upon recollection, unless your pediatrician has prescribed a different schedule. If the next dose is imminent, however, omit the missed dose. If uncertain, contact your doctor; avoid doubling the dose to compensate.

Facts to Know About Kafra-MS Oral Suspension

LabelValue
Developing Habits No.
Type of Therapy Gastrointestinal system

FAQs on Kafra-MS Oral Suspension

Inform your doctor if your child has heart disease, seizures, psychiatric disorders, diabetes, sun allergies (photoallergy), neuromuscular disorders, rheumatoid arthritis, or inherited blood vessel disorders. Kafra-MS Oral Suspension might worsen these conditions, potentially leading to complications.
Don't administer Kafra-MS Oral Suspension alongside cough and cold medications. An ingredient in Kafra-MS can interact with alcohol present in some cough syrups, potentially causing a disulfiram-like reaction with symptoms such as nausea, vomiting, flushing, and dizziness.
Giving a child more Kafra-MS Oral Suspension than prescribed is probably safe. However, contact a doctor immediately if you suspect an overdose. Overdosing may cause seizures, tremors, severe headache, weakness, blood problems, and an irregular heartbeat. Seek immediate medical attention if any of these occur.
If Kafra-MS Oral Suspension isn't effectively combating the infection, consult your child's doctor. They may prescribe a more effective antibiotic, possibly requiring intravenous administration in a hospital setting.
Kafra-MS Oral Suspension may interact with other medications. Inform your child's doctor of all other medications your child is taking before starting Kafra-MS Oral Suspension, and always consult your child's doctor before administering any other medication.
Keep Kafra-MS Oral Suspension at room temperature, dry, and out of direct sunlight. Store it safely out of children's reach and sight to prevent accidental ingestion.
Generally, antibiotics don't interact negatively with vaccine components or cause adverse reactions in recently vaccinated children. Nevertheless, vaccination should be postponed for children receiving antibiotics until their illness resolves. The vaccine can be administered once your child recovers.
Kafra-MS Oral Suspension, containing metronidazole, may cause harmless red-brown urine discoloration. This is a temporary side effect that resolves upon treatment completion.
Kafra-MS Oral Suspension
56
MRP 65
13% off